JUL 05, 2020 1:19 PM PDT

New Drug May Reduce Inflammation from COVID-19

WRITTEN BY: Annie Lennon

Scientists from the University of Toronto have identified a new drug candidate that may reduce all kinds of inflammation. In particular, they said that it might be able to target cytokine storms- a potentially deadly sort of inflammatory response that can come by COVID-19 infection. 

Known as TAT CARMIL1, the drug is a combination of two naturally-occurring peptides or small proteins. When combined, they are reportedly able to infiltrate cell membranes and lessen acute inflammatory responses. In particular, the scientists say that the TAT CARMIL1 peptide targets two receptors, attaching itself to the cell’s surface and substrate, where it can then attach itself to other cells too.

In an ex vivo study, the researchers found that the peptide treatment was able to interfere with inflammation-causing cells known as interleukin1, and reduce the degradation of collagen, an abundant protein known as the body’s ‘scaffolding’, by up to 43%. 

If used early enough, they say that the drug may prevent some of the worst damage caused by acute inflammatory responses. Given that one of the primary causes of death from COVID-19 is by cytokine storm- a natural inflammatory response from the body to rid itself of acute infection- the researchers are hopeful it may one day be applied against the virus. 

The scientists are now hoping to test the drug’s effectiveness in in-vitro models. As the peptides are broadly applicable, they can be combined to many drugs. These potentially include treatments for cancer and arthritis, meaning the drug discovery could be useful one day to fight against many different kinds of inflammation. 

Nevertheless, the researchers caution that before we get excited about the drug’s potential prospects, we should wait for further tests. This comes especially as their study so far shows that that the peptide is most effective when applied early on in infection, making it somewhat impractical. 

“In the clinical world, the reality is that you don’t have that luxury,” says Greg Downey, one of the study’s co-authors. 

 

Sources: Genetic Engineering and Biotechnology NewsBusiness Standard

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 18, 2020
Drug Discovery & Development
Gilead to Trial COVID-19 Drug on Children
JUN 18, 2020
Gilead to Trial COVID-19 Drug on Children
Following the emergency use authorization given to Remdesivir on May 1, Gilead Sciences has announced that it will condu ...
JUN 17, 2020
Drug Discovery & Development
Treating Atherosclerosis
JUN 17, 2020
Treating Atherosclerosis
The two main proponents for atherosclerotic plaque and inflammation is an increase in cholesterol and macrophage presenc ...
JUN 23, 2020
Drug Discovery & Development
FDA Warns Against Toxic Hand Sanitizers
JUN 23, 2020
FDA Warns Against Toxic Hand Sanitizers
The COVID-19 pandemic has seen demand for hand sanitizers soar in recent months. As such, the Food and Drug Administrati ...
JUL 13, 2020
Drug Discovery & Development
Russia Completes First Human Trial for COVID-19 Vaccine
JUL 13, 2020
Russia Completes First Human Trial for COVID-19 Vaccine
The Sechenov University Center for Clinical Research in Moscow, Russia, has completed its first round of clinical trials ...
JUL 15, 2020
Microbiology
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
JUL 15, 2020
A Common Drug Could Help Reduce the Risk of COVID-19 Infections
Heparin is a very common drug that's been approved as an anticoagulant since 1992. Researchers have now found that the m ...
JUL 19, 2020
Cannabis Sciences
Cannabis May Relieve Pain from Sickle Cell Disease
JUL 19, 2020
Cannabis May Relieve Pain from Sickle Cell Disease
Due to the rise in opioid-associated deaths, physicians and researchers are on the constant lookout for new, healthier o ...
Loading Comments...